Russell Investments Group’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.53M Buy
232,177
+191,731
+474% +$3.68M ﹤0.01% 1444
2026
Q1
$713K Sell
40,446
-45,111
-53% -$906K ﹤0.01% 2373
2025
Q4
$1.67M Buy
85,557
+44,635
+109% +$802K ﹤0.01% 1974
2025
Q3
$714K Buy
40,922
+12,998
+47% +$193K ﹤0.01% 2325
2025
Q2
$391K Sell
27,924
-53,569
-66% -$863K ﹤0.01% 2436
2025
Q1
$1.51M Buy
+81,493
New +$1.22M ﹤0.01% 1853
2024
Q2
Sell
-2,925
Closed -$14.5K 3577
2024
Q1
$14.5K Buy
+2,925
New +$18.7K ﹤0.01% 2808
2023
Q4
Sell
-27,849
Closed -$193K 3205
2023
Q3
$193K Buy
27,849
+20,588
+284% +$124K ﹤0.01% 2499
2023
Q2
$41.7K Sell
7,261
-73,947
-91% -$478K ﹤0.01% 2748
2023
Q1
$516K Sell
81,208
-103,481
-56% -$987K ﹤0.01% 2247
2022
Q4
$2.17M Sell
184,689
-105,007
-36% -$1.28M ﹤0.01% 1541
2022
Q3
$3.44M Buy
+289,696
New +$4.23M 0.01% 1268

Other funds holding ALHC

Russell Investments Group's ALHC Position: Q2 2026 in Review

Russell Investments Group increased its Alignment Healthcare (ALHC) stake by 474% in Q2 2026, buying an estimated $3.68M and bringing the position to 232,177 shares worth $5.53M. The position accounts for ﹤0.01% of the portfolio, ranked #1444.

Russell Investments Group first reported a position in ALHC in Q3 2022 and has held it in 12 quarters since. 152 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.

  • Russell Investments Group held 232,177 shares of Alignment Healthcare worth $5.53M as of Q2 2026.
  • Russell Investments Group bought 191,731 Alignment Healthcare shares in Q2 2026, an estimated $3.68M.
  • Alignment Healthcare made up ﹤0.01% of Russell Investments Group's portfolio in Q2 2026, its #1444 holding.
  • Russell Investments Group first reported a position in Alignment Healthcare in Q3 2022 and has held it in 12 quarters since.
  • 152 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.

Based on Russell Investments Group's 13F filing for Q2 2026, filed 6 Aug 2026.